Skip to main content
. Author manuscript; available in PMC: 2017 Aug 22.
Published in final edited form as: J Biopharm Stat. 2016 Aug 22;26(6):1083–1097. doi: 10.1080/10543406.2016.1226335

Table 1.

Diagnostic Yield of New Screening Test T Compared with Standard Test S for Colorectal Cancer (CRC), 100,000 Subjects.

Disease Test Positives Test Negatives
Status S+ T+ Δ+ S T Δ
Absent 4965 14895 9930 94335 84405 −9930
Presenta 525 630 105 175 70 −105

Ratio 9.5 23.6 94.6 539.1 1205.8 94.6
FP AEsb 33.8 101.3 67.5
ΔFP AEsTP 0.64

a

Prevalence of disease (CRC) is assumed to be 0.7%, or 700 per 100,000 subjects.

b

Risk of an adverse event during colonoscopy is assumed to be 0.68% (Rutter et al, 2012, Table 2). All subjects falsely testing positive are assumed to be referred to colonoscopy and undergo the procedure.